• 1. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
• 2. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 3. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
• 4. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 5. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Comprehensive Overview of tert-butyl 2-(methylcarbamoyl)pyrrolidine-1-carboxylate (CAS No. 88815-87-6)

tert-butyl 2-(methylcarbamoyl)pyrrolidine-1-carboxylate (CAS No. 88815-87-6) is a specialized organic compound widely utilized in pharmaceutical research and fine chemical synthesis. This compound, often referred to as a pyrrolidine derivative, plays a crucial role in the development of bioactive molecules due to its unique structural properties. The presence of both tert-butyl and methylcarbamoyl groups enhances its stability and reactivity, making it a valuable intermediate in modern drug discovery.

The chemical structure of tert-butyl 2-(methylcarbamoyl)pyrrolidine-1-carboxylate features a five-membered pyrrolidine ring, which is a common motif in many biologically active compounds. This ring system is known for its conformational flexibility, allowing it to interact effectively with various biological targets. The carbamate and tert-butyl ester functionalities further contribute to its versatility, enabling its use in a wide range of chemical transformations.

In recent years, the demand for tert-butyl 2-(methylcarbamoyl)pyrrolidine-1-carboxylate has surged, particularly in the field of medicinal chemistry. Researchers are increasingly exploring its potential as a building block for the synthesis of novel drug candidates, especially those targeting neurological and metabolic disorders. Its compatibility with parallel synthesis and combinatorial chemistry techniques has made it a favorite among chemists working on high-throughput screening projects.

One of the most notable applications of tert-butyl 2-(methylcarbamoyl)pyrrolidine-1-carboxylate is in the development of protease inhibitors. These inhibitors are critical in the treatment of various diseases, including viral infections and certain types of cancer. The compound's ability to mimic natural peptide substrates makes it an ideal candidate for designing potent and selective inhibitors. Additionally, its steric hindrance properties can be leveraged to fine-tune the pharmacokinetic profiles of resulting drug molecules.

The synthesis of tert-butyl 2-(methylcarbamoyl)pyrrolidine-1-carboxylate typically involves multi-step organic reactions, starting from readily available pyrrolidine precursors. Key steps often include N-Boc protection, carbamoylation, and esterification. Advanced purification techniques such as column chromatography and recrystallization are employed to ensure high purity, which is essential for its use in sensitive pharmaceutical applications.

From a commercial perspective, tert-butyl 2-(methylcarbamoyl)pyrrolidine-1-carboxylate is supplied by several specialized chemical manufacturers. The compound is usually available in research quantities, with prices varying based on purity and supplier. Given its importance in drug development, many companies offer custom synthesis services to meet the specific needs of pharmaceutical clients. Quality control measures, including HPLC analysis and NMR spectroscopy, are strictly followed to guarantee batch-to-batch consistency.

Environmental and safety considerations for tert-butyl 2-(methylcarbamoyl)pyrrolidine-1-carboxylate are in line with standard laboratory practices for organic compounds. While not classified as hazardous under normal handling conditions, it is recommended to use appropriate personal protective equipment when working with this chemical. Proper storage conditions, typically in a cool, dry place under inert atmosphere, help maintain its stability over extended periods.

Looking ahead, the future of tert-butyl 2-(methylcarbamoyl)pyrrolidine-1-carboxylate appears promising, particularly with the growing emphasis on targeted drug delivery systems. Its structural features make it an attractive candidate for conjugation with various drug carriers, potentially enhancing therapeutic efficacy while minimizing side effects. Furthermore, ongoing research into biocatalysis may open new, more sustainable routes for its production, aligning with the pharmaceutical industry's push toward greener chemistry.

For researchers interested in exploring the potential of tert-butyl 2-(methylcarbamoyl)pyrrolidine-1-carboxylate, numerous scientific publications detail its synthesis and applications. Recent studies have demonstrated its utility in creating allosteric modulators for various receptors, as well as its incorporation into peptidomimetic scaffolds. These developments underscore the compound's continued relevance in cutting-edge pharmaceutical research.

In conclusion, tert-butyl 2-(methylcarbamoyl)pyrrolidine-1-carboxylate (CAS No. 88815-87-6) represents a versatile and valuable tool in modern chemical research. Its unique combination of structural features and synthetic accessibility ensures its ongoing importance in the development of new therapeutic agents. As drug discovery approaches become increasingly sophisticated, this compound is likely to maintain its position as a key building block in medicinal chemistry.

• 149152-54-5(1-Pyrrolidinecarboxylic acid, 2-[(dimethylamino)carbonyl]-,1,1-dimethylethyl ester, (2S)-)
• 105959-87-3(L-Prolinamide, 1-[(1,1-dimethylethoxy)carbonyl]-D-prolyl-N-methyl-)
• 110139-27-0(1-Pyrrolidinecarboxylic acid, 2-[(dodecylamino)carbonyl]-,1,1-dimethylethyl ester, (S)-)
• 65519-33-7(Glycinamide, 1-[(1,1-dimethylethoxy)carbonyl]-L-prolyl-N-methyl-)
• 74360-79-5((S)-tert-butyl 2-(methylcarbamoyl)pyrrolidine-1-carboxylate)
• 103137-94-6(L-Alaninamide,1-[(1,1-dimethylethoxy)carbonyl]-L-prolylglycyl-N-methyl- (9CI))
• 155251-70-0((S)-tert-Butyl 2-(pyrrolidine-1-carbonyl)pyrrolidine-1-carboxylate)
• 103137-93-5(L-Alaninamide,1-[(1,1-dimethylethoxy)carbonyl]-L-prolyl-D-alanyl-N-methyl- (9CI))
• 105959-86-2(L-Prolinamide, 1-[(1,1-dimethylethoxy)carbonyl]-L-prolyl-N-methyl-)
• 89226-14-2((S)-1-Boc-2-(Piperidine-1-carbonyl)pyrrolidine)